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SHORT COMMUNICATION
Inhibition by neostigmine of hepatocarcinogenesis induced by
N-nitrosomorpholine in Sprague-Dawley rats
M. Tatsuta, H. lishi, M. Baba, H. Uehara & A. Nakaizumi
Department ofGastrointestinal Oncology, The Centerfor Adult Diseases, Osaka, 3-3, Nakamichi 1-chome, Higashinari-ku,
Osaka 537, Japan.
Several investigators (Kato & Shimazu, 1983; Lamar &
Holloway, 1977) have suggested that liver regeneration after
partial hepatectomy is affected by vagotomy. Maros (1970)
reported that subdiaphragmatic vagotomy markedly sup-
pressed cell proliferation after partial hepatectomy. These
findings suggest that the parasympathetic nervous system is
closely involved in hepatocarcinogenesis. Therefore, in the
present work we examined in rats the effect of prolonged
administration of the parasympathomimetic agent neostig-
mine methyl sulphate on hepatocarcinogenesis.
Fifty young (6-week-old) male Sprague-Dawley rats (SLC
Inc., Shizuoka, Japan) were randomly divided into two
groups and were treated as follows. Group 1 (25 rats) was
given the vehicle only (plain olive oil) every other day until
the end of experimental week 18. From week 3, animals were
also given drinking water containing 250mgl1' of N-nitro-
somorpholine (NNM; Sigma Chemical Co., St Louis, MO,
USA) for 8 weeks. The NNM was dissolved in distilled water
at a concentration of 50 g 1 ' and was stored in a cool place.
The stock solution was diluted to 250 mg ml- ' with tap water
just before use, and 30 ml of this solution (which is less than
any rat consumes in 48 h) were given to each rat from the
bottles ad libitum. The bottles were replenished every other
day after confirming that they were empty. When there was
residual solution in the bottles, it was given intragastrically to
control the dose of NNM. From week 11 until the end of the
experiment, rats were given normal tap water only. Group 2
(25 rats) received alternate-day s.c. injections of neostigmine
methyl sulphate (Sigma) at a dose of 0.1 mg kg-' body
weight, as a suspension in olive oil. From week 3, animals
were given NNM for 8 weeks in the same way as group 1.
At week 18, the rats (non-fasted) were killed by ether
anaesthesia. The liver was immediately excised, and 2-mm
slices obtained from the left lobe were immediately mounted
on a brass chuck using OCT compound, frozen in dry ice-
acetone (-86°C), and stored at -70°C. Serial 6 tm cryostat
sections obtained from the frozen liver slices were also
incubated in cold acetone (0-4°C) from 10 min and were
stained with haematoxylin and eosin. Staining for y-glutamyl
transpeptidase (GGT) activity and adenylate cyclase activity
was performed as described by Ruttenberg et al. (1969) and
by Mayer et al. (1985), respectively.
Serial sections were scored for GGT-positive hepatic
lesions and adenylate cyclase-positive hepatic lesions. The
transectional area of the hepatic lesions in the plane of the
tissue section and the area of the entire liver section were
measured with a PIAS LA-500 Personal Image Analyzer
System (Tokyo, Japan). From the measured area of transec-
tion of the lesions, the number of lesions per unit volume of
liver was estimated by the method of Pugh et al. (1983), and
the mean volume of the lesions per unit liver volume was
calculated by the method of Campbell et al. (1982).
The labelling indices of the enzyme-altered hepatic lesions
and the surrounding liver were examined in weeks 9 and 18.
The labelling index was measured with an immunohisto-
chemical analysis kit for assay of bromodeoxyuridine (BrdU)
incorporation (Becton-Dickinson, Mountain View, CA,
USA) (Gratzner, 1982; Morstyn et al., 1983) by a modifi-
cation of the method described by Tada et al. (1985). To
obtain the labelling index, the numbers of BrdU-labelled cells
were counted among 500 cells in the surrounding liver and in
enzyme-altered hepatic lesions of 0.7-1.2 mm largest dia-
meter. The labelling index was expressed as the percentage of
labelled cells per total number of cells examined.
Results were analysed by Student's t test (Snedecor &
Cochran, 1967). Data are given as means ± s.e. 'Significant'
indicates a calculated P value of less than 0.05.
Five rats in group 1 and three rats in group 2 were killed
in week 9 for examination of labelling indices of the enzyme-
altered hepatic lesions and adjacent normal liver. No rats in
group 1 died before week 18, but four rats in group 2 died
before week 18. These were excluded from effective numbers.
Table I summarises the number, size and volume of GGT-
positive and adenylate cyclase-positive hepatic lesions in
NNM-treated rats. The two-dimensional data show that
GGT-positive lesions and adenylate cyclase-positive lesions
had a significantly smaller area (as per cent of parenchyma)
in group 2 (neostigmine) than in group 1 (olive oil). Statis-
tical analysis of the calculated volumetric data also shows
that the number of GGT-positive hepatic lesions per cm3 and
the volumes (as per cent of the parenchyma) of GGT-positive
hepatic lesions and adenylate cyclase-positive hepatic lesions
were significantly less in group 2 than in group 1.
Table II summarises the number, size and- volume of
hepatocellular carcinomas in NNM-treated rats. Both the
observed transectional data and the calculated volumetric
data show that the incidence of hepatocellular carcinoma was
significantly lower in group 2 (neostigmine) than in group 1
(olive oil).
Table III summarises the data on the labelling indices of
pre-neoplastic hepatic lesions and adjacent normal liver for
the NNM-treated rats. Group 2 rats treated with neostigmine
had significantly lower labelling indices for pre-neoplastic
hepatic lesions and adjacent liver than group 1 rats treated
with olive oil only, at both times examined.
Acetylcholine has been demonstrated to be capable of
influencing cell division (Byron, 1973). Gurkalo & Volfson
(1982) examined the effect of nicotine on the development of
gastric cancers induced by N-methyl-N'-nitro-N-nitroso-
guanidine, and found that parasympathomimetic agents
inhibit carcinogenesis. However, thus far there have been no
reports regarding the effect of cholinoceptor stimulation on
hepatocyte proliferation.
Liver regeneration after partial hepatectomy is affected by
vagotomy. Lamar & Holloway (1977) found that vagotomy
at the cervical level significantly reduced the incorporation of
labelled thymidine into liver DNA after partial hepatectomy.
Maros (1970) found that liver cell proliferation after partial
hepatectomy was markedly suppressed by subdiaphragmatic
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Table I Number, size and volume ofGGT-positive hepatic lesions and adenylate cyclase-positive hepatic
lesions in NNM-treated rats
GGT-positive lesions Adenylate cyclase-positive lesions
Group 1 Group 2 Group 1 Group 2
(olive oil) (neostigmine) (olive oil) (neostigmine)
Observed transectional data of lesions
No. per cm2 23±2 14±3 32±4 16±2a
Mean area (mm2) 0.65±0.05 0.54±0.06 1.02±.011 1.04±0.19
Area as per cent of parenchyma 15.34± 1.77 7.55± 1.73b 29.36±2.56 15.16±2.73a
Calculated volumetric data of lesions
No. per cm3 292.8±35.4 190.9±32.2c 257.0±38.9 152.8±37.9
Mean volume (mm3) 0.59±0.07 0.41 ±0.06 1.39±0.19 1.52±0.37
Volume as per cent of 15.34± 1.77 7.55± 1.73a 29.36±2.56 15.16±2.73a
parenchyma
Treatment regimens. Olive oil: NNM was given orally for 8 weeks, and animals received alternate-day
injectionsofthevehicle (plain oliveoil) only. Neostigmine: NNM wasgiven orally for8 weeks, and animals
received alternate-day injection ofneostigmine as a suspension in olive oil. Significantly different from the
value for group 1: aP<0.05; bp<0.01; cP<0.005.
Table II Number, size and volume of hepatocellular carcinomas in
NNM-treated rats
Group 1 Group 2
(olive oil) (neostigmine)
Observed transectional
data of lesion
No. per cm2 2.2±0.4 0.4±0.2b
Mean area (mm2) 1.01 ±0.19 1.22±0.70
Area as per cent of parenchyma 3.19±0.92 1.69±0.72
Calculated volumetric
data of lesion
No. per cm3 20.9±6.4 1.2± 0.7a
Mean volume (mm3) 2.06±0.53 4.46± 1.95
Volume as per cent of 3.19±0.92 1.69±0.72
parenchyma
ForexplanationoftreatmentsseeTableI. Significantlydifferentfrom
the value for group 1: aP<0.01; bp<o.oos.
Table III Labelling indices of the enzyme-altered hepatic lesions and adjacent normal
liver
No. of Labelling index (%)
Experi- enzyme-
mental Group altered lesions Enzyme-altered Adjacent
week no. Treatment examined hepatic lesion liver
9 1 Olive oil 30 3.4±0.1 1.5±0.1
2 Neostigmine 30 2.0±0.la 0.7±0.la
18 1 Olive oil 30 3.6±0.1 1.2±0.1
2 Neostigmine 30 2.3±0.la 0.8±0.la
For explanation of treatments see Table I. aSignificantly different from the value for
group 1: P<0.001.
vagotomy. Moreover, Kato & Shimizu (1983) reported that
the increase in DNA synthesis after partial hepatectomy was
suppressed by subdiaphragmatic vagotomy. Recently, how-
ever, Tanaka et al. (1987) examined the effects of hepatic
vagotomy (sectioning of the hepatic branch of the vagus
nerve) on liver regeneration after partial hepatectomy. These
authors found that hepatic vagotomy delayed but did not
suppress the increase in the rate of hepatic DNA systhesis.
Kino (1988) also obtained similar results. In the present
work, however, we found that prolonged alternate-day
administration of neostigmine significantly reduced the label-
ling indices for pre-neoplastic hepatic lesions and for adjacent
normal liver.
Our present results indicate that the parasympathetic ner-
vous system may be closely involved in hepatocarcinogenesis
although the dose of neostigmine was very high and the
decrease in GGT positive foci relatively modest.
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